You are here

  • Home
  • Archive
  • Volume 71, Issue 1
  • Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

Article metrics

Article menu
Download PDFPDF
Hepatology
Original research
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

 

Online download statistics by month:

Online download statistics by month: January 2021 to February 2023

AbstractFullPdf
Jan 2021141710576
Feb 20218483426
Mar 20213612722
Apr 20213202513
May 2021104157
Jun 2021212012
Jul 202120196
Aug 202113129
Sep 20211096
Oct 202111057737
Nov 202110242921
Dec 202114387851
Jan 20228536836
Feb 20225224424
Mar 20224484930
Apr 2022309226
May 20223362211
Jun 20223152918
Jul 20223872133
Aug 2022214104
Sep 20222151711
Oct 20223151920
Nov 20222951519
Dec 20222621811
Jan 202313887
Feb 202315514
Total11445793520